juMPStart: Phase 1, Open-Label, Dose-Escalation Safety and Efficacy Gene Therapy Study Evaluating HMI-203 in Adults with MPS II

Gerry Shioshita, Jennifer Henrick, Cecile Verhofstadt, et al.